<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8044166</article-id><article-id pub-id-type="publisher-id">87381</article-id><article-id pub-id-type="doi">10.1038/s41598-021-87381-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Anti-<italic>Acanthamoeba</italic> synergistic effect of chlorhexidine and <italic>Garcinia mangostana</italic> extract or &#x003b1;-mangostin against <italic>Acanthamoeba triangularis</italic> trophozoite and cyst forms</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sangkanu</surname><given-names>Suthinee</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Mitsuwan</surname><given-names>Watcharapong</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Mahabusarakam</surname><given-names>Wilawan</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Jimoh</surname><given-names>Tajudeen O.</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wilairatana</surname><given-names>Polrat</given-names></name><address><email>polrat.wil@mahidol.ac.th</email></address><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Girol</surname><given-names>Ana Paula</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Verma</surname><given-names>Ajoy K.</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>de Lourdes Pereira</surname><given-names>Maria</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Rahmatullah</surname><given-names>Mohammed</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Wiart</surname><given-names>Christophe</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Siyadatpanah</surname><given-names>Abolghasem</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name><surname>Norouzi</surname><given-names>Roghayeh</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name><surname>Mutombo</surname><given-names>Polydor Ngoy</given-names></name><xref ref-type="aff" rid="Aff14">14</xref><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Nissapatorn</surname><given-names>Veeranoot</given-names></name><address><email>nissapat@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.412867.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 0043 6347</institution-id><institution>School of Allied Health Sciences, Southeast Asia Water Team (SEA Water Team), World Union for Herbal Drug Discovery (WUHeDD), and Research Excellence Center for Innovation and Health Products (RECIHP), </institution><institution>Walailak University, </institution></institution-wrap>Nakhon Si Thammarat, Thailand </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.412867.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 0043 6347</institution-id><institution>Akkhraratchakumari Veterinary College and Research Center of Excellence in Innovation of Essential Oil, Walailak University, </institution></institution-wrap>Nakhon Si Thammarat, Thailand </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.7130.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0470 1162</institution-id><institution>Division of Physical Science, Faculty of Science, </institution><institution>Prince of Songkla University, </institution></institution-wrap>Songkhla, Thailand </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.7922.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 0244 7875</institution-id><institution>Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, </institution><institution>Chulalongkorn University, </institution></institution-wrap>Bangkok, Thailand </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.442655.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 0042 4901</institution-id><institution>Department of Biochemistry, Habib Medical School, </institution><institution>Islamic University in Uganda, </institution></institution-wrap>Kampala, Uganda </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.10223.32</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0490</institution-id><institution>Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, </institution><institution>Mahidol University, </institution></institution-wrap>Bangkok, Thailand </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.410543.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 2188 478X</institution-id><institution>Department of Biology, Faculty of Sciences, </institution><institution>S&#x000e3;o Paulo State University, </institution></institution-wrap>S&#x000e3;o Paulo, Brazil </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.419345.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 1767 7309</institution-id><institution>Department of Microbiology, </institution><institution>National Institute of Tuberculosis &#x00026; Respiratory Diseases (NITRD), </institution></institution-wrap>New Delhi, India </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.7311.4</institution-id><institution-id institution-id-type="ISNI">0000000123236065</institution-id><institution>Department of Medical Sciences, </institution><institution>CICECO-Aveiro Institute of Materials &#x00026;, University of Aveiro, </institution></institution-wrap>Aveiro, Portugal </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.443057.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 4683 7084</institution-id><institution>Department of Biotechnology &#x00026; Genetic Engineering, </institution><institution>University of Development Alternative Lalmatia, </institution></institution-wrap>Dhaka, Bangladesh </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="GRID">grid.440435.2</institution-id><institution>School of Pharmacy, </institution><institution>University of Nottingham Malaysia Campus, </institution></institution-wrap>Selangor, Malaysia </aff><aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="GRID">grid.411701.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0417 4622</institution-id><institution>Ferdows School of Paramedical and Health, </institution><institution>Birjand University of Medical Sciences, </institution></institution-wrap>Birjand, Iran </aff><aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="GRID">grid.412831.d</institution-id><institution-id institution-id-type="ISNI">0000 0001 1172 3536</institution-id><institution>Department of Pathobiology, Faculty of Veterinary Medicine, </institution><institution>University of Tabriz, </institution></institution-wrap>Tabriz, Iran </aff><aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="GRID">grid.1005.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 4902 0432</institution-id><institution>School of Public Health and Community Medicine, </institution><institution>UNSW Medicine, UNSW, </institution></institution-wrap>Sydney, NSW Australia </aff><aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="GRID">grid.1056.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2224 8486</institution-id><institution>Centre for Biomedical Research, </institution><institution>Burnet Institute, </institution></institution-wrap>Melbourne, VIC Australia </aff></contrib-group><pub-date pub-type="epub"><day>13</day><month>4</month><year>2021</year></pub-date><pub-date pub-type="pmc-release"><day>13</day><month>4</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>11</volume><elocation-id>8053</elocation-id><history><date date-type="received"><day>5</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>25</day><month>3</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2021</copyright-statement><license><ali:license_ref specific-use="pmc" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1"><italic>Acanthamoeba</italic> spp. can cause amoebic keratitis (AK). Chlorhexidine is effective for AK treatment as monotherapy, but with a relative failure on drug bioavailability in the deep corneal stroma. The combination of chlorhexidine and propamidine isethionate is recommended in the current AK treatment. However, the effectiveness of treatment depends on the parasite and virulence strains. This study aims to determine the potential of <italic>Garcinia mangostana</italic> pericarp extract and &#x003b1;-mangostin against <italic>Acanthamoeba triangularis</italic>, as well as the combination with chlorhexidine in the treatment of <italic>Acanthamoeba</italic> infection. The minimal inhibitory concentrations (MICs) of the extract and &#x003b1;-mangostin were assessed in trophozoites with 0.25 and 0.5&#x000a0;mg/mL, for cysts with 4 and 1&#x000a0;mg/mL, respectively. The MIC of the extract and &#x003b1;-mangostin inhibited the growth of <italic>A. triangularis</italic> trophozoites and cysts for up to 72&#x000a0;h. The extract and &#x003b1;-mangostin combined with chlorhexidine demonstrated good synergism, resulting in a reduction of 1/4&#x02013;1/16 of the MIC. The SEM results showed that <italic>Acanthamoeba</italic> cells treated with a single drug and its combination caused damage to the cell membrane and irregular cell shapes. A good combination displayed by the extract or &#x003b1;-mangostin and chlorhexidine, described for the first time. Therefore, this approach is promising as an alternative method for the management of <italic>Acanthamoeba</italic> infection in the future.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Drug discovery</kwd><kwd>Plant sciences</kwd><kwd>Diseases</kwd><kwd>Health care</kwd><kwd>Pathogenesis</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2021</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2"><italic>Acanthamoeba</italic> is an opportunistic amoeba distributed in diverse natural habitats<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. This organism have two main forms: the trophozoite, an invasive stage; and cyst, a highly resistant stage in a very harsh conditions<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. Based on the size, shape and features of cysts, <italic>Acanthamoeba</italic> spp. have been divided into three groups (I, II, III). However, <italic>Acanthamoeba</italic> spp. has been classified into 22 different genotypes (T1&#x02013;T22 Genotype) based on molecular technique, which used 18S rRNA gene sequencing<sup><xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref></sup>. Among them, T4 genotyge is the most isolated in clinical and environmental samples, followed by genotypes T3 and T5. In addition, the T4 genotype is the most virulent because it has a significant potential for binding to host cells than other genotypes<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>.</p><p id="Par3"><italic>Acanthamoeba</italic> spp. are the causative agents of amoebic keratitis (AK) and granulomatous amoebic encephalitis (GAE). AK can cause permanent loss of vision<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. The rate of infectious keratitis is becoming alarming in recent times, a problem that may be related to a sudden increase in the population of contact lens wearers<sup><xref ref-type="bibr" rid="CR2">2</xref></sup> Similarly, <italic>Acanthamoeba</italic> encysts penetrated deeply into the corneal stroma<sup><xref ref-type="bibr" rid="CR8">8</xref></sup> as such, the cyst wall becomes impervious to existing drugs, and this becomes a drawback for further studies in the areas of drug formulations and designed for this organism.</p><p id="Par4"><italic>Garcinia mangostana</italic> Linn. is generally known as mangosteen and belongs to the family <italic>Clusiaceae</italic>. It is a tropical tree, widely distributed in Southeast Asia<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. The pericarps of this fruit are commonly used in traditional medicine to treat several diseases which are non-toxic and safe to use<sup><xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup>. Major compound in the mangosteen pericarps is xanthone group, particularly &#x003b1;-mangostin, which exhibited antibacterial activity<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>, antifungal activity<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>, antioxidant activity<sup><xref ref-type="bibr" rid="CR14">14</xref></sup> anti-cancer activity<sup><xref ref-type="bibr" rid="CR15">15</xref>&#x02013;<xref ref-type="bibr" rid="CR17">17</xref></sup>, anti-inflammatory activity<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR19">19</xref></sup>, antiparasitic activity<sup><xref ref-type="bibr" rid="CR20">20</xref>&#x02013;<xref ref-type="bibr" rid="CR22">22</xref></sup>.</p><p id="Par5">To the best of our knowledge, we discover that there is no single report on the anti-<italic>Acanthamoeba</italic> activity of <italic>G. mangostana</italic> extract to date. Hence, our study sought to investigate the effective concentration of the <italic>G. mangostana</italic> extract and &#x003b1;-mangostin on the growth inhibition of <italic>Acanthamoeba</italic> spp. and to demonstrate its synergistic effects combined with chlorhexidine on anti-<italic>Acanthamoeba</italic> activity.</p></sec><sec id="Sec2"><title>Results</title><sec id="Sec3"><title>Genotypic and species identification of <italic>Acanthamoeba</italic> isolate WU19001</title><p id="Par6">The partial nucleotide sequences of DF3 region of <italic>Acanthamoeba</italic> sp. WU19001 from our previous study aligned using CLUSTAL W and revealed the highest variation, as shown in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>. The 18S rDNA sequences were subjected to phylogenetic analysis and species identification. It showed very similar patterns to <italic>Acanthamoeba triangularis</italic> KX232518.1 (99.74% similarity). The sequence homology search for the 35 <italic>Acanthamoeba</italic> spp. in the National Center for Biotechnology Information (NCBI) database showed WU19001 formed <italic>Acanthamoeba</italic> genotype T4 cluster (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). The nucleotide sequence of WU19001 has been deposited at Genbank under the accession number MW647650.<fig id="Fig1"><label>Figure 1</label><caption><p>Primary sequence alignment of the DF3 region using CLUSTAL W. The region shown a subset of the total DF3 region which demonstrates the highest variation. Asterisks denote similarities and dashes denote gaps within the nucleotide sequences.</p></caption><graphic xlink:href="41598_2021_87381_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Figure 2</label><caption><p>A phylogenetic tree was constructed using the neighbour-joining method with the Kimura two-parameter algorithm with bootstrapping values for 1000 replicates. The tree was reconstructed by considering 35 <italic>Acanthamoeba</italic> spp. isolates with the reference strains from NCBI.</p></caption><graphic xlink:href="41598_2021_87381_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec4"><title>Minimum inhibitory concentration (MIC)</title><p id="Par7"><italic>G. mangostana</italic> extract and &#x003b1;-mangostin were determined for their anti-<italic>Acanthamoeba</italic> potential by MIC using the microtiter dilution broth method. As shown in Table <xref rid="Tab1" ref-type="table">1</xref>, the MICs of <italic>G. mangostana</italic> extract against <italic>A. triangularis</italic> trophozoites and cysts were 0.25 and 4&#x000a0;mg/mL. The pure compound, &#x003b1;-mangostin, exhibited MIC values at 0.5 and 1&#x000a0;mg/mL for trophozoites and cysts. The MIC values of chlorhexidine against trophozoites and cysts were 0.008 and 0.064&#x000a0;mg/mL, respectively.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Minimal inhibitory concentration (MIC) of <italic>G. mangostana</italic> extract, &#x003b1;-mangostin and chlorhexidine against <italic>A. triangularis</italic> trophozoites and cysts.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Antimicrobial agents</th><th align="left" colspan="2">MIC (mg/mL)</th></tr><tr><th align="left">Trophozoites</th><th align="left">Cysts</th></tr></thead><tbody><tr><td align="left"><italic>G. mangostana</italic> extract</td><td char="." align="char">0.25</td><td align="left">4</td></tr><tr><td align="left">&#x003b1;-mangostin</td><td char="." align="char">0.5</td><td align="left">1</td></tr><tr><td align="left">Chlorhexidine</td><td char="." align="char">0.008</td><td align="left">0.064</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec5"><title>Growth assay</title><p id="Par8">Susceptibilities of <italic>A. triangularis</italic> to <italic>G. mangostana</italic> extract and &#x003b1;-mangostin were determined by growth assay. <italic>A. triangularis</italic> was found to be significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) susceptible to the extract and &#x003b1;-mangostin at all concentrations when compared to control. The extract and &#x003b1;-mangostin showed higher susceptibility against <italic>Acanthamoeba</italic> trophozoites than cysts. (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). After 72&#x000a0;h incubation, MIC values of the extract and &#x003b1;-mangostin could decrease the viability to 0.15&#x02009;&#x000d7;&#x02009;10<sup>5</sup> and 0.1&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells/mL of trophozoites as compared to the control (6.0&#x02009;&#x000d7;&#x02009;10<sup>5</sup>) (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>a,b).<fig id="Fig3"><label>Figure 3</label><caption><p><italic>G. mangostana</italic> extract and &#x003b1;-mangostin inhibit the growth of <italic>A. triangularis</italic> trophozoites and cysts in vitro. To determine the effect of <italic>G. mangostana</italic> extract and &#x003b1;-mangostin on trophozoites (<bold>a</bold>,<bold>b</bold>) and on cysts (<bold>c</bold>,<bold>d</bold>), assays were performed by inoculating 2&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells/mL in PYG medium in the presence of <italic>G. mangostana</italic> extract or &#x003b1;-mangostin at MIC, 0.5&#x02009;&#x000d7;&#x02009;MIC and 0.25&#x02009;&#x000d7;&#x02009;MIC final concentrations. The inhibitory activity was carried out using trypan blue exclusion assay up to 72&#x000a0;h; 1% DMSO was used as a negative control.</p></caption><graphic xlink:href="41598_2021_87381_Fig3_HTML" id="MO3"/></fig></p><p id="Par9">After 24&#x000a0;h of incubation, the number of <italic>Acanthamoeba</italic> cysts decreased to 2.3&#x02009;&#x000d7;&#x02009;10<sup>5</sup> and 0.8&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells/mL when treated with MIC concentration of the extract and &#x003b1;-mangostin, respectively. We observed the re-growth which reached to the number of viable cells of 1.4&#x02009;&#x000d7;&#x02009;10<sup>5</sup> and 2.2&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells/mL in the presence of the extract and &#x003b1;-mangostin at 72&#x000a0;h of incubation. However, the treated cysts showed a decrease in viable cells when compared with the control that reached up to 5.8&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells/mL at 72&#x000a0;h of incubation (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>c,d).</p></sec><sec id="Sec6"><title>Synergistic effects</title><p id="Par10">The evaluation of the synergistic effects between the plant extract and the drug was determined in this study. For <italic>A. triangularis</italic> trophozoites, an additive interaction (FICI&#x02009;=&#x02009;1) was observed in the combination of chlorhexidine and the extract. Chlorhexidine at 0.002&#x000a0;mg/mL was synergistic when combined with &#x003b1;-mangostin at 0.032, 0.062 and 0.125&#x000a0;mg/mL (Table <xref rid="Tab2" ref-type="table">2</xref>). For the cystic form, chlorhexidine was synergistic when combined with the extract and &#x003b1;-mangostin. With the extract, synergism was observed in 0.004, 0.008 and 0.016&#x000a0;mg/mL of chlorhexidine when combined with the extract 0.5 and 1&#x000a0;mg/mL. In addition, chlorhexidine at 0.004 and 0.008&#x000a0;mg/mL was found to be synergistic with various concentrations (0.062, 0.125 and 0.25 mg/mL) of &#x003b1;-mangostin (Table <xref rid="Tab3" ref-type="table">3</xref>). The percentage of viability in <italic>A. triangularis</italic> in additive and synergistic effects was less than 10% (Figs. <xref rid="Fig4" ref-type="fig">4</xref> and <xref rid="Fig5" ref-type="fig">5</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Fractional inhibitory concentration index (FICI) of the combination test in targeting <italic>A. triangularis</italic> trophozoites.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Combination agents</th><th align="left" colspan="2">MIC in combination (mg/mL)</th><th align="left" rowspan="2">FICI</th><th align="left" rowspan="2">Effect</th></tr><tr><th align="left">Chlorhexidine</th><th align="left">Extract or &#x003b1;-mangostin</th></tr></thead><tbody><tr><td align="left"><italic>G. mangostana</italic> extract</td><td char="." align="char">0.004</td><td char="." align="char">0.125</td><td align="left">1</td><td align="left">Additivity</td></tr><tr><td align="left" rowspan="3">&#x003b1;-mangostin</td><td char="." align="char">0.002</td><td char="." align="char">0.032</td><td align="left">0.31</td><td align="left">Synergistic</td></tr><tr><td char="." align="char">0.002</td><td char="." align="char">0.062</td><td align="left">0.37</td><td align="left">Synergistic</td></tr><tr><td char="." align="char">0.002</td><td char="." align="char">0.125</td><td align="left">0.50</td><td align="left">Synergistic</td></tr></tbody></table></table-wrap><table-wrap id="Tab3"><label>Table 3</label><caption><p>Fractional inhibitory concentration index (FICI) of the combination test in targeting <italic>A. triangularis</italic> cysts.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Combination agents</th><th align="left" colspan="2">MIC in combination (mg/mL)</th><th align="left" rowspan="2">FICIFICI</th><th align="left" rowspan="2">Effect</th></tr><tr><th align="left">Chlorhexidine</th><th align="left">Extract or &#x003b1;-mangostin</th></tr></thead><tbody><tr><td align="left" rowspan="5"><italic>G. mangostana</italic> extract</td><td align="left">0.004</td><td align="left">0.5</td><td align="left">0.18</td><td align="left">Synergistic</td></tr><tr><td align="left">0.004</td><td align="left">1</td><td align="left">0.31</td><td align="left">Synergistic</td></tr><tr><td align="left">0.008</td><td align="left">0.5</td><td align="left">0.24</td><td align="left">Synergistic</td></tr><tr><td align="left">0.008</td><td align="left">1</td><td align="left">0.37</td><td align="left">Synergistic</td></tr><tr><td align="left">0.016</td><td align="left">0.5</td><td align="left">0.36</td><td align="left">Synergistic</td></tr><tr><td align="left" rowspan="8">&#x003b1;-mangostin</td><td align="left">0.004</td><td align="left">0.062</td><td align="left">0.12</td><td align="left">Synergistic</td></tr><tr><td align="left">0.004</td><td align="left">0.125</td><td align="left">0.18</td><td align="left">Synergistic</td></tr><tr><td align="left">0.004</td><td align="left">0.250</td><td align="left">0.31</td><td align="left">Synergistic</td></tr><tr><td align="left">0.008</td><td align="left">0.062</td><td align="left">0.18</td><td align="left">Synergistic</td></tr><tr><td align="left">0.008</td><td align="left">0.125</td><td align="left">0.24</td><td align="left">Synergistic</td></tr><tr><td align="left">0.008</td><td align="left">0.250</td><td align="left">0.37</td><td align="left">Synergistic</td></tr><tr><td align="left">0.008</td><td align="left">0.125</td><td align="left">0.24</td><td align="left">Synergistic</td></tr><tr><td align="left">0.008</td><td align="left">0.062</td><td align="left">0.18</td><td align="left">Synergistic</td></tr></tbody></table></table-wrap><fig id="Fig4"><label>Figure 4</label><caption><p>Combination of <italic>G. mangostana</italic> extract or &#x003b1;-mangostin with chlorhexidine for anti-amoebic effects on trophozoites of <italic>A. triangularis.</italic> Parasites were grown in PYG medium in the presence of chlorhexidine alone and combination with <italic>G. mangostana</italic> extract (<bold>a</bold>) or &#x003b1;-mangostin (<bold>b</bold>) for 24&#x000a0;h. The inhibitory activity was carried out using trypan blue exclusion assay; 1% DMSO was used as negative control (<bold>c</bold>). Treated trophozoites were observed under inverted microscopy (20x). The relative percentage of viability was defined as (mean of the treated /mean of the control)&#x02009;&#x000d7;&#x02009;100. *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, statistically significant difference in combination to single drug treatment.</p></caption><graphic xlink:href="41598_2021_87381_Fig4_HTML" id="MO4"/></fig><fig id="Fig5"><label>Figure 5</label><caption><p>Combination of <italic>G. mangostana</italic> extract or &#x003b1;-mangostin with chlorhexidine for anti-amoebic effects on cysts of <italic>A. triangularis.</italic> Parasites were grown in PYG medium in the presence of chlorhexidine alone and combination with <italic>G. mangostana</italic> extract (<bold>a</bold>) or &#x003b1;-mangostin (<bold>b</bold>) for 24&#x000a0;h. The inhibitory activity was carried out using trypan blue exclusion assay; 1% DMSO was used as a negative control (<bold>c</bold>). Treated cysts were observed under inverted microscopy (40x). The relative percentage of viability was defined as (mean of the treated /mean of the control)&#x02009;&#x000d7;&#x02009;100. *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, statistically significant difference in combination to single drug treatment.</p></caption><graphic xlink:href="41598_2021_87381_Fig5_HTML" id="MO5"/></fig></p></sec><sec id="Sec7"><title>SEM analysis</title><p id="Par11">The alterations due to the action of <italic>G. mangostana</italic> extract and &#x003b1;-mangostin were confirmed by SEM micrograph are shown in Figs. <xref rid="Fig6" ref-type="fig">6</xref> and <xref rid="Fig7" ref-type="fig">7</xref>. Control trophozoites (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>a) treated with 1% DMSO exhibited normal cells with acanthopodia. During the treatment with the extract (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>b), the damaged cells were observed as flat and smooth surface. For treatment with MIC of chlorhexidine and &#x003b1;-mangostin, the trophozoites reduced in size, shrunken appearance, loss of acanthapodia, and having pores-like structure on the surface as shown in Fig. <xref rid="Fig6" ref-type="fig">6</xref>c,d. Trophozoites treated with the combination of chlorhexidine and the extract at FICI equal 1, SEM showed rounded morphology with pores on the cell surface (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>e). In combination with chlorhexidine and &#x003b1;-mangostin, trophozoites have died completely with a rough surface and tiny when compared to the control (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>f). Also, micrographs of control cysts were intact with oval shape and smooth surface as shown in Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>a. The oval cysts of <italic>A. triangularis</italic> were flat, irregular in shape, causing a collapse of the ectocyst walls after treatment with chlorhexidine, the extract, &#x003b1;-mangostin and in combination (Fig. <xref rid="Fig7" ref-type="fig">7</xref>b&#x02013;f).<fig id="Fig6"><label>Figure 6</label><caption><p>Scanning micrographs of <italic>A. triangularis</italic> trophozoites after treatment with <italic>G. mangostana</italic> extract, chlorhexidine, &#x003b1;-mangostin and in combination at 24&#x000a0;h. Control trophozoites (<bold>a</bold>), trophozoites treated with G<italic>. mangostana</italic> extract (1&#x000a0;mg/mL) (<bold>b</bold>), &#x003b1;-mangostin (0.5&#x000a0;mg/mL) (<bold>c</bold>), chlorhexidine (0.008&#x000a0;mg/mL) (<bold>d</bold>), and combination of chlorhexidine (0.004&#x000a0;mg/mL) and <italic>G. mangostana</italic> extract (0.125&#x000a0;mg/mL) (<bold>e</bold>), combination of chlorhexidine (0.002&#x000a0;mg/mL) and &#x003b1;-mangostin (0.032&#x000a0;mg/mL) (<bold>f</bold>). Magnification: (<bold>a</bold>&#x02013;<bold>f</bold>)&#x02009;=&#x02009;&#x000d7;&#x000a0;5000.</p></caption><graphic xlink:href="41598_2021_87381_Fig6_HTML" id="MO6"/></fig><fig id="Fig7"><label>Figure 7</label><caption><p>Scanning micrographs of <italic>A. triangularis</italic> cysts after treatment with <italic>G. mangostana</italic> extract, chlorhexidine, &#x003b1;-mangostin and in combination at 24&#x000a0;h. Control cysts (<bold>a</bold>), cysts were treated with G<italic>. mangostana</italic> extract (16&#x000a0;mg/mL) (<bold>b</bold>), &#x003b1;-mangostin (4&#x000a0;mg/mL) (<bold>c</bold>), chlorhexidine (2.56&#x000a0;mg/mL) (<bold>d</bold>), and combination of chlorhexidine (0.004&#x000a0;mg/mL) and <italic>G. mangostana</italic> extract (0.5&#x000a0;mg/mL) (<bold>e</bold>), combination of chlorhexidine (0.04&#x000a0;mg/mL) and &#x003b1;-mangostin (0.062&#x000a0;mg/mL) (<bold>f</bold>). Magnification: (<bold>a</bold>&#x02013;<bold>f</bold>)&#x02009;=&#x02009;&#x000d7;&#x000a0;5000.</p></caption><graphic xlink:href="41598_2021_87381_Fig7_HTML" id="MO7"/></fig></p></sec><sec id="Sec8"><title>Toxicity</title><p id="Par12">At low concentrations, ranging from 0.032&#x02013;0.062&#x000a0;mg/mL for <italic>G. mangostana</italic> extract, the number of living cells were constant at 24&#x000a0;h. However, the survival of Vero cells tended to be lower than those after treatments with the extract (0.125&#x02013;4&#x000a0;mg/mL) (Fig. <xref rid="MOESM1" ref-type="media">S2</xref>a). For &#x003b1;-mangostin, the surviving Vero cells were observed at 0.008&#x02013;0.016&#x000a0;mg/mL (non-toxic) but decreased at the concentrations of 0.032&#x02013;1&#x000a0;mg/mL (Fig. <xref rid="MOESM1" ref-type="media">S2</xref>b). The effect of &#x003b1;-mangostin on Vero cells was further determined according to IC<sub>50</sub> value, which was obtained from the viable interpolation of the cell line. Pure &#x003b1;-mangostin exhibited an inhibitory effect on Vero cells with IC<sub>50</sub> value 0.016&#x000a0;mg/mL (39&#x000a0;&#x003bc;M) after 24&#x000a0;h of treatment (Fig. <xref rid="MOESM1" ref-type="media">S2</xref>c). To reduce the toxicity, a combination sets of &#x003b1;-mangostin and chlorhexidine treatment was further challenged to determine the survival of Vero cells. However, it was clearly observed the decreased survial when the concentration of &#x003b1;-mangostin was higher than 0.016&#x000a0;mg/mL (data were not shown).</p></sec></sec><sec id="Sec9"><title>Discussion</title><p id="Par13">The herb-drug interaction may impact to the potential health-promoting effect of increasing drug efficacy or decreasing common adverse effect. As such, we present in this study an effective treatment for <italic>A. triangularis</italic> infection with herb-drug based combination strategy. Also, we highlight the potential of the anti-<italic>Acanthamoeba</italic> activity of <italic>G. mangostana</italic> which also known as the &#x0201c;queen of fruits&#x0201d;.</p><p id="Par14">In previous literature, xanthones is a major phytochemical compound from <italic>G. mangostana</italic> which have been presented in several parts of plant such as pericarp, whole fruits, leaves and bark<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. The pericarp of mangosteen fruit are the most abundant of xanthones &#x003b1;-mangostin (78% total xanthone content)<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. In addition, there are various components of other xanthones, such as &#x003b2;-mangostin, gartanin, 8-deoxygartanin, garcinones A, B, C, D and E, mangostinone, 9-hydroxycalabaxanthone, and isomangostin<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR24">24</xref></sup>. Nevertheless, previous studies have reported that the concentration of &#x003b1;-mangostin correlates with the biological activity of mangosteen extract<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. Interestingly, the compound &#x003b1;-mangostin from <italic>G. mangostana</italic> has ever been reported its property against other parasites like <italic>Plasmodium falciparum</italic><sup><xref ref-type="bibr" rid="CR22">22</xref></sup>.</p><p id="Par15">Some studies have reported the effects of <italic>G. mangostana</italic> extract and &#x003b1;-mangostin on anti-parasitic activity<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>, but the effect on <italic>Acanthamoeba</italic> spp. has so far never been explored. Our study therefore demonstrated for the first time of <italic>G. mangostana</italic> extract from the pericarp and &#x003b1;-mangostin exhibit anti-<italic>Acanthamoeba</italic> activity against <italic>A. triangularis</italic> trophozoites and cysts. <italic>A. triangularis</italic> WU19001 was a selected strain parasite used in this study due to its characteristic property belong to group II (genotype T4). Group 2 <italic>Acanthamoeba</italic> species are pathogenic in nature, typically having double-walled with a wrinkled ectocyst and stellate polygonal, triangular, or oval endocyst<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. <italic>A. triangularis</italic> was originally isolated from human faeces<sup><xref ref-type="bibr" rid="CR27">27</xref></sup> and currently discovered from environmental water souces, as reported in this study. In 2008, the pathogenic strain of <italic>A. triangularis</italic> has firstly reported in a clinically confirmed case of <italic>Acanthamoeba</italic> keratitis in Korea<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. Due to climate change and global warming, it is postulated that <italic>A. triangularis</italic> would be more likely to be associated to clinical scenario in times to come as it is widely contaminated in the environment.</p><p id="Par16">In fact, eradicating <italic>Acanthamoeba</italic> infection seems impossible due to the high resistance of the cysts to anti-<italic>Acanthamoeba</italic> drugs. Therefore, we also investigated the effective concentration of <italic>G. mangostana</italic> extract and &#x003b1;-mangostin against <italic>A. triangualris</italic> trophozoite and cyst stages. Our results showed that the extract and &#x003b1;-mangostin can inhibit <italic>A. triangularis</italic> in PYG medium. It is noteworthy that the number of <italic>Acanthamoeba</italic> trophozoites and cysts were significantly reduced (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) in the treatment with MIC concentrations of the extract and &#x003b1;-mangostin. They were found to have the greatest growth-inhibitor for trophozoites at 72&#x000a0;h. For the cystic form, they survived on 72&#x000a0;h (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>) which might be due to the decreased the decreased effect of the extract and &#x003b1;-mangostin. In addition, the cyst form is a is a dormant stage against severe condition, including the presence of anti-<italic>Acanthamoeba</italic> agents<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. Overall, this study therefore suggests that the extract and &#x003b1;-mangostin are promising agents that shows the remarkable effects against <italic>A. triangularis</italic> infections. However, the development method for support the stability of the extract and &#x003b1;-mangostin has been validated since it is important for further pharmacokinetic or tissue distribution ex vivo studies.</p><p id="Par17">Chlorhexidine is the drug of choice for treatment <italic>Acanthamoeba</italic> keratitis, since it is effective against both trophozoites and cysts<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. In this study, a single drug chlorhexidine was studied on anti-<italic>Acanthamoeba</italic> activity and prosperously exhibited inhibitory activity in <italic>A. triangularis</italic> trophozoites and cysts with MIC values of 0.008 and 0.064&#x000a0;mg/mL (Table <xref rid="Tab1" ref-type="table">1</xref>), respectively. According to an earlier report, chlorhexidine showed amoebicidal and cysticidal properties at 200&#x000a0;&#x003bc;g/mL (0.02%), but it exhibited side effects<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. In fact, a single drug, used to treat infectious diseases, includes this parasitic infection that causes side effects, long-term for clearance use, high cost and drug-resistant parasites. Therefore, the combination approach is constantly being introduced to find these pitfalls. Chlorhexidine has often been used in combination with aromatic diamidines<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>, aminoglycosides, imidazoles, and polyene<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. However, these chemicals have side effects on keratocytes found in cases of human keratitis<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. Recently, the discovery of compounds with anti-<italic>Acanthamoeba</italic> activity in plants and herbs has been very encouraging to evaluate a source of secondary metabolites with anti-<italic>Acanthamoeba</italic> effects. The combination test for possible synergistic effects against <italic>Acanthamoeba</italic> spp. was considered to reduce the MIC of the drug. To support this, our study also revealed the effect of the combination of <italic>G. mangostana</italic> extract and chlorhexidine against <italic>A. triangularis</italic> trophozoites and cysts. Chlorhexidine showed an additive effect when combined with the <italic>G. mangostana</italic> extract. An additive effect occurs when the substance added to increase or improve the effectiveness but not to the extent of synergistic interaction<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. <italic>G. mangostana</italic> extract was combined with chlorhexidine to produce a synergistic effect against <italic>A. triangularis</italic> cysts. The FICI values demonstrated the synergy for concentration of 0.004 to 0.016&#x000a0;mg/mL of chlorhexidine and 0.5 to 1&#x000a0;mg/mL of <italic>G. mangostana</italic> extract as shown the viability of less than 10%. The &#x003b1;-mangostin was found to be more effective when combined with chlorhexidine. It is interesting to note that the concentration of chlorhexidine can be reduce by 1/4&#x02013;1/16 of the MIC in the presence of &#x003b1;-mangostin. Nowadays, it is difficult and expensive to develop new drugs, therefore it has been considered the finding of alternative strategies to reduce toxicity and/or the development of resistance pathogens. From this study, it appears to be a promising combined chlorhexidine with <italic>G. mangostana</italic> extract or &#x003b1;-mangostin to fight infection and especially the resistance pattern of <italic>Acanthamoeba</italic> spp. in the future.</p><p id="Par18">The mode of action considered in this study was confirmed by scanning electron microscopy (SEM), as shown in Figs. <xref rid="Fig6" ref-type="fig">6</xref> and <xref rid="Fig7" ref-type="fig">7</xref>. Treated trophozoites showed similar flat cells and smooth surfaces as a result of the total destruction of acanthopodia in the presence of extract and chlorhexidine. Regarding the combination of the drug and <italic>G. mangostana</italic> extract or &#x003b1;-mangostin, the morphology of trophozoites being observed in the presence of pores on their surface and cells were rounded and small. Chlorhexidine is positively and ionically charged with the parasite&#x000b4;s negatively charged plasma membrane, resulting in the membrane structure that gives rise to permeability modulation, ionic leakage and cytoplasmic disruptions causing cellular damage and cell death<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup><bold>.</bold> Control cysts showed regular morphological characteristics. Overall, <italic>A. triangularis</italic> cysts were flat and morphologically deformed (of irregular shape and size) as a result of the destruction of the ectocyst walls after the treatment given with <italic>G. mangostana</italic> extract, &#x003b1;-mangostin, chlorhexidine and in combination.</p><p id="Par19">For a pure compound, &#x003b1;-mangostin exhibited toxicity to Vero cells at IC<sub>50</sub> values 39&#x000a0;&#x003bc;M (0.016&#x000a0;mg/mL). Our preliminary finding is however surprisingly different from a previous study reported that &#x003b1;-mangostin was non-toxic to nontumorigenic human pancreatic duct epithelial cells, at a dose as high as 40&#x000a0;&#x003bc;M<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. In addition, xanthones in <italic>G. mangostana</italic> pericarp proved to be non-toxic to mice in vivo when administered orally at a dose of 100&#x000a0;mg/kg of body weight/day for 7&#x000a0;days<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. Since &#x003b1;-mangostin is gaining more popular to be used against infectious diseases, therefore, it strongly suggests for further comprehensive studies such as chemical structure modification and structure&#x02013;activity relationship as well as nanotechnology to evaluate the mechanism of action of these compounds against <italic>Acanthamoeba</italic> spp., before any conclusion could be made.</p><p id="Par20">Besed on the results obtained from this study, ethanolic extract of <italic>G. mangostana</italic> from the pericarp and &#x003b1;-mangostin possess anti-<italic>Acanthamoeba</italic> activities against <italic>A. triangularis</italic> trophozoite and cyst stages. Moreover, the present study focuses on the novel combination for treatment of <italic>Acanthamoeba</italic> infection. The combination of <italic>G. mangostana</italic> extract and &#x003b1;-mangostin with chlorhexidine generated synergistic effects which increased effectively for the treatment of <italic>Acantrhamoeba</italic> infection.</p></sec><sec id="Sec10"><title>Materials and methods</title><sec id="Sec11"><title>Preparation of plant extracts</title><p id="Par21">The 50&#x000a0;g of dry <italic>G. mangostana</italic> pericarp powder was soaked in 200&#x000a0;mL of ethanol for 7&#x000a0;days. The extract was filtered through Whatman No. 1 (GE Healthcare Life Science, Buckinghamshire HP7 9NA, United Kingdom) using a vacuum and pressure pump. The solution was evaporated to dryness under reduced pressure using a rotary evaporator to obtain <italic>G. mangostana</italic> extract. The 200 mg of extract was subjected to column chromatography using silica gel as a stationary phase and eluted with 20% acetone in 750 mL of hexane. The collected fractions were chromatographed on a silica gel thin-layer chromatography compared with the authentic compound, &#x003b1;-mangostin. Fractions with one spot of &#x003b1;-mangostin on chromatogram were combined. The solvent was removed to give 30 mg yellow solid of &#x003b1;-mangostin. The extract and &#x003b1;-mangostin were dissolved in 99.5% DMSO and stored at &#x02212;&#x000a0;20&#x000a0;&#x000b0;C until use.</p></sec><sec id="Sec12"><title>Cultivation of <italic>A. triangularis</italic></title><p id="Par22"><italic>A. triangularis</italic> WU19001, a strain from the recreational reservoir at Walailak University, Nakhon Si Thammarat-Thailand, was used in this study<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. The parasite was grown in PYG medium [20&#x000a0;g proteose peptone, 2&#x000a0;g yeast extract, 0.98&#x000a0;g MgSO<sub>4</sub>&#x000b7;7H<sub>2</sub>O, 0.35&#x000a0;g Na<sub>2</sub>HPO<sub>4</sub>&#x000b7;7H<sub>2</sub>O, 0.34&#x000a0;g KH<sub>2</sub>PO<sub>4</sub>, 0.02&#x000a0;g (NH<sub>4</sub>)<sub>2</sub>Fe(SO<sub>4</sub>)<sub>2</sub>&#x000b7;6H<sub>2</sub>O, 18&#x000a0;g glucose]. The trophozoites were observed after 72&#x000a0;h of incubation at room temperature and were cultured in this medium for 1&#x000a0;week The 90% mature cysts were obtained PYG medium. The cysts were harvested when the cultures were incubated for at least 1&#x000a0;week without addition fresh medium. The parasite reproduced exponentially until they reached the maximum level of 1&#x02009;&#x000d7;&#x02009;10<sup>6</sup> cells/mL, after which a reduced nutrients led to encystation (cyst formation) due to unfavorable conditions for the parasite&#x02019;s growth especially into trophozoite stage. At the end, all fully homogenic inoculum of mature cysts were successfully harvested. Trophozoites and cysts were centrifuged at 4000&#x000a0;rpm for 5&#x000a0;min and re-suspended in fresh PYG thereafter. For counting, 50 &#x003bc;L of cell suspension was mixed with 50 &#x003bc;L of trypan blue. Viability was investigated under the inverted microscope based on the principle of the dye can cross the membrane of dead cells with blue color, but not intact membrane of viable cells with colorless appearances.</p></sec><sec id="Sec13"><title>Minimal inhibitory concentration (MIC)</title><p id="Par23">The minimum inhibitory concentration (MIC) for <italic>G. mangostana</italic> extract and &#x003b1;-mangostin was determined using the microtiter broth dilution method<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. The extract and &#x003b1;-mangostin were diluted to give a final concentration of 4, 2, 1, 0.5, 0.25, 0.125, 0.062&#x000a0;mg/mL in a 96-well microplate. Then 100&#x000a0;&#x000b5;L of 2&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells/mL of trophozoites and cysts were inoculated into each well. Chlorhexidine and 1% DMSO were included as a positive and negative control, respectively. The plates were incubated at room temperature for 24&#x000a0;h. The viability of parasites was calculated as follows: % viability&#x02009;=&#x02009;(mean of the viable parasite/control)&#x02009;&#x000d7;&#x02009;100. The MIC value was defined as the lowest concentration that inhibited&#x02009;&#x0003e;&#x02009;90% of viable growth when compared with the control.</p></sec><sec id="Sec14"><title>Growth assay</title><p id="Par24">In the present study, the growth inhibition on <italic>A. triangularis</italic> of <italic>G. mangostana</italic> extract and &#x003b1;-mangostin was carried out following the procedure that previously described<sup><xref ref-type="bibr" rid="CR1">1</xref></sup> with modifications. The trophozoites and cysts (2&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells/mL) were incubated with the extract and &#x003b1;-mangostin in the MIC, 0.5&#x02009;&#x000d7;&#x02009;MIC and 0.25&#x02009;&#x000d7;&#x02009;MIC, except for untreated control tubes, which had only PYG medium and incubated at room temperature for 72&#x000a0;h. At 24&#x000a0;h intervals, the viability of parasite was determined by staining with 0.2% trypan blue.</p></sec><sec id="Sec15"><title>Drug combinations</title><p id="Par25">The checkerboard method<sup><xref ref-type="bibr" rid="CR39">39</xref></sup> was used to evaluate the interaction between <italic>G. mangostana</italic> extract/&#x003b1;-mangostin and chlorhexidine against <italic>A. triangularis</italic>. Subsequently, the microdilution assay was performed in a 96-well plate with a final volume of 200 &#x000b5;L. The extract, &#x003b1;-mangostin and chlorhexidine were diluted with PYG to obtain 4 times to their final concentrations of 1/16 MIC, 1/8 MIC, 1/4 MIC, 1/2 MIC and MIC. A total of 100 &#x000b5;L of the extract&#x02009;+&#x02009;chlorhexidine or &#x003b1;-mangostin&#x02009;+&#x02009;chlorhexidine were prepared in 96-well plate and added 100 &#x000b5;L of parasite suspension containing 2&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells/mL into the wells. The plates were incubated at room temperature for 24&#x000a0;h. The viability of parasite was defined as the lowest concentration that inhibited&#x02009;&#x0003e;&#x02009;90% of growth when compared to the negative control. The assessment of the results was defined as the Fractional Inhibitory Concentration Index (FICI), which was calculated using the following:<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{FICI}}\;{\text{of}}\;{\text{combination}} = {\text{FIC}}\;{\text{A}} + {\text{FIC}}\;{\text{B}}$$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mrow><mml:mtext>FICI</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>of</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>combination</mml:mtext><mml:mo>=</mml:mo><mml:mtext>FIC</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>A</mml:mtext><mml:mo>+</mml:mo><mml:mtext>FIC</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>B</mml:mtext></mml:mrow></mml:math><graphic xlink:href="41598_2021_87381_Article_Equa.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equb"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{FIC}}\;{\text{A}} = {\text{MIC}}\;{\text{of}}\;{\text{chlorhexidine}}\;{\text{in}}\;{\text{combination}}/{\text{MIC}}\;{\text{of}}\;{\text{chlorhexidine}}\;{\text{alone}}$$\end{document}</tex-math><mml:math id="M4" display="block"><mml:mrow><mml:mtext>FIC</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>A</mml:mtext><mml:mo>=</mml:mo><mml:mtext>MIC</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>of</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>chlorhexidine</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>in</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>combination</mml:mtext><mml:mo stretchy="false">/</mml:mo><mml:mtext>MIC</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>of</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>chlorhexidine</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>alone</mml:mtext></mml:mrow></mml:math><graphic xlink:href="41598_2021_87381_Article_Equb.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equc"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{FIC}}\;{\text{B}} = {\text{MIC}}\;{\text{of}}\;{\text{extract}}\;{\text{in}}\;{\text{combination}}/{\text{MIC}}\;{\text{of}}\;{\text{extract}}\;{\text{alone}}.$$\end{document}</tex-math><mml:math id="M6" display="block"><mml:mrow><mml:mtext>FIC</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>B</mml:mtext><mml:mo>=</mml:mo><mml:mtext>MIC</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>of</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>extract</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>in</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>combination</mml:mtext><mml:mo stretchy="false">/</mml:mo><mml:mtext>MIC</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>of</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>extract</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>alone</mml:mtext><mml:mo>.</mml:mo></mml:mrow></mml:math><graphic xlink:href="41598_2021_87381_Article_Equc.gif" position="anchor"/></alternatives></disp-formula></p><p id="Par26">The combination was considered synergistic for FICI&#x02009;&#x02264;&#x02009;0.5, additive for 0.5&#x02009;&#x0003c;&#x02009;FICI&#x02009;&#x02264;&#x02009;1, indifferent for 1&#x02009;&#x0003c;&#x02009;FICI&#x02009;&#x0003c;&#x02009;4, and antagonistic for FICI&#x02009;&#x02265;&#x02009;4, according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) definition.</p></sec><sec id="Sec16"><title>Scanning electron microscopic (SEM) study</title><p id="Par27">Trophozoites and cysts of <italic>A. triangularis</italic> were treated with chlorhexidine, <italic>G. mangostana</italic> extract, &#x003b1;-mangostin and in combinations. After incubation, cells were collected by centrifugation at 4000&#x000a0;rpm for 5&#x000a0;min and re-suspended in phosphate buffer saline (PBS). Cells in 1% DMSO were used as negative controls. Samples were fixed with 2.5% glutaraldehyde overnight. The samples were further dehydrated with a series of graded alcohol (20%, 40%, 60%, 80%, 90%, and 100% ethanol), mounted on aluminum stubs, and allowed to dry using a critical point dryer. Samples were then coated with gold particles and the morphology of <italic>A. triangularis</italic> trophozoites and cysts after treatment was subsequently examined under SEM (SEM-Zeiss, Munich, Germany) at the Center for Scientific and Technological Equipment, Walailak University, Nakhon Si Thammarat, Thailand<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>.</p></sec><sec id="Sec17"><title>Toxicity</title><p id="Par28">The cytotoxic effects of <italic>G. mangostana</italic> extract, &#x003b1;-mangostin, chlorhexidine and combination sets were evaluated using the Vero cell line (8200F270602). Cells were cultured in Dulbecco's Modified Eagle's (DMEM) medium (Merck KGaA, Darmstadt, Germany) supplemented with 10% FBS and 1% antibiotic containing penicillin G of 100 units/mL, streptomycin of 100&#x000a0;&#x003bc;g/mL. The culture was incubated at 37&#x000a0;&#x000b0;C in a humidified atmosphere and 5% CO<sub>2</sub>. After the cells reached 90% confluence, detachment was performed using trypsin ethylene diamine tetraacetic acid (EDTA), incubated at 37&#x000a0;&#x000b0;C in 5% CO<sub>2</sub>. Single cells at a density of 1.5&#x02009;&#x000d7;&#x02009;10<sup>4</sup> cells/100 &#x003bc;L were seeded into each well of a 96-well polystyrene plate and allowed to attach for 24&#x000a0;h. Then, 100 &#x003bc;L of the extract and &#x003b1;-mangostin, previously prepared at multiple concentrations, chlorhexidine and combination sets were gently added. After incubation for 24&#x000a0;h, the cytotoxic effects were determined using the MTT assay. The absorbance was measured using a microplate reader (Biotek, Cork, Ireland) at 570&#x000a0;nm. The percent survival was calculated using the following equation:<disp-formula id="Equd"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\% \;{\text{survival}} = \left( {{\text{ABt}}/{\text{ABu}}} \right) \times {1}00$$\end{document}</tex-math><mml:math id="M8" display="block"><mml:mrow><mml:mo>%</mml:mo><mml:mspace width="0.277778em"/><mml:mtext>survival</mml:mtext><mml:mo>=</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mtext>ABt</mml:mtext><mml:mo stretchy="false">/</mml:mo><mml:mtext>ABu</mml:mtext></mml:mrow></mml:mfenced><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math><graphic xlink:href="41598_2021_87381_Article_Equd.gif" position="anchor"/></alternatives></disp-formula></p><p id="Par29">ABt and ABu denote the absorbance values of treated and untreated cells, respectively<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>.</p></sec><sec id="Sec18"><title>Statistical analysis</title><p id="Par30">The experiments were performed in triplicate. All data were recorded and entered using the statistical package software (SPSS Inc. Chicago, IL, USA). The data were expressed as mean&#x02009;&#x000b1;&#x02009;SD. Statistical analysis was analyzed by the two-tailed unpaired Student&#x02019;s t-test. In all analyzes, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 was considered statistically significant.</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary Information</title><sec id="Sec19"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2021_87381_MOESM1_ESM.pdf"><caption><p>Supplementary Information.</p></caption></media></supplementary-material></p></sec></sec></body><back><fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1038/s41598-021-87381-x.</p></sec><ack><title>Acknowledgements</title><p>We highly appreciate for the support of The Royal Patronage of Her Royal Highness Princess Maha Chakri Sirindhorn&#x02014;Botanical Garden of Walailak University, Nakhon Si Thammarat under the project entitled: Medicinal under-exploited Thai native plant against <italic>Acanthamoeba</italic>, <italic>Leishmania donovani</italic>, and <italic>Plasmodium falciparum</italic>&#x02014;Toward South East Asia collaboration initiative (WUBG020-2564), Thailand, Research Institute of Health Science (RIHS), Walailak University for the laboratory facilities, and Assoc. Prof. Dr. Chuchard Punsawad, School of Medicine, Walailak University for providing human Vero cell line. We would also like to acknowledge the project CICECO-Aveiro Institute of Materials, UIDB/50011/2020 and UIDP/50011/2020, national funds by FCT/MCTES.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>S.S. performed all the laboratory work, analyzed the data and wrote a draft of the paper; P.W. and V.N. conceived the idea, designed the experiments related to natural products and parasitology, and overlooked in the laboratory work; W.M. assisted in the experiments; All authors read, reviewed, edited, agreed, and approved for the submission of the finalized manuscript.</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par31">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>D</given-names></name><name><surname>Miles</surname><given-names>H</given-names></name><name><surname>Toney</surname><given-names>D</given-names></name><name><surname>Ngyuen</surname><given-names>C</given-names></name><name><surname>Marciano-Cabral</surname><given-names>F</given-names></name></person-group><article-title>Amebicidal activity of plant extracts from Southeast Asia on <italic>Acanthamoeba</italic> spp</article-title><source>Parasitol. Res.</source><year>1998</year><volume>84</volume><fpage>746</fpage><lpage>752</lpage><pub-id pub-id-type="doi">10.1007/s004360050480</pub-id><pub-id pub-id-type="pmid">9766904</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sifaoui</surname><given-names>I</given-names></name><etal/></person-group><article-title>Evaluation of the anti-<italic>Acanthamoeba</italic> activity of two commercial eye drops commonly used to lower eye pressure</article-title><source>Exp. Parasitol.</source><year>2017</year><volume>183</volume><fpage>117</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/j.exppara.2017.07.012</pub-id><pub-id pub-id-type="pmid">28778743</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tice</surname><given-names>AK</given-names></name><etal/></person-group><article-title>Expansion of the molecular and morphological diversity of Acanthamoebidae (Centramoebida, Amoebozoa) and identification of a novel life cycle type within the group</article-title><source>Biol. Direct.</source><year>2016</year><volume>11</volume><fpage>69</fpage><pub-id pub-id-type="doi">10.1186/s13062-016-0171-0</pub-id><?supplied-pmid 28031045?><pub-id pub-id-type="pmid">28031045</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haniloo</surname><given-names>A</given-names></name><name><surname>Pezeshki</surname><given-names>A</given-names></name><name><surname>Mahmmodzadeh</surname><given-names>A</given-names></name><name><surname>Kadkhodamohammadi</surname><given-names>E</given-names></name></person-group><article-title>Genotyping of <italic>Acanthamoeba</italic> spp. from water sources from Northwestern Iran</article-title><source>Acta Parasitol.</source><year>2017</year><volume>62</volume><fpage>790</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1515/ap-2017-0095</pub-id><pub-id pub-id-type="pmid">29035854</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coronado-Vel&#x000e1;zquez</surname><given-names>D</given-names></name><etal/></person-group><article-title><italic>Acanthamoeba mauritaniensis</italic> genotype T4D: An environmental isolate displays pathogenic behavior</article-title><source>Parasitol. Int.</source><year>2019</year><volume>74</volume><fpage>102002</fpage><pub-id pub-id-type="doi">10.1016/j.parint.2019.102002</pub-id><?supplied-pmid 31669294?><pub-id pub-id-type="pmid">31669294</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>M</given-names></name><name><surname>Thongseesuksai</surname><given-names>T</given-names></name><name><surname>Boonmars</surname><given-names>T</given-names></name><name><surname>Laummaunwai</surname><given-names>P</given-names></name></person-group><article-title>Investigation of the <italic>in vitro</italic> cysticidal activity of miltefosine against <italic>Acanthamoeba</italic> spp</article-title><source>J. Parasites Dis.</source><year>2020</year><volume>44</volume><fpage>491</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1007/s12639-020-01204-w</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walochnik</surname><given-names>J</given-names></name><etal/></person-group><article-title>Granulomatous amoebic encephalitis caused by <italic>Acanthamoeba</italic> amoebae of genotype T2 in a human immunodeficiency virus-negative patient</article-title><source>J. Clin. Microbiol.</source><year>2008</year><volume>46</volume><fpage>338</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1128/JCM.01177-07</pub-id><pub-id pub-id-type="pmid">18003807</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenzo-Morales</surname><given-names>J</given-names></name><name><surname>Khan</surname><given-names>NA</given-names></name><name><surname>Walochnik</surname><given-names>J</given-names></name></person-group><article-title>An update on <italic>Acanthamoeba</italic>keratitis: Diagnosis, pathogenesis and treatment</article-title><source>Parasites</source><year>2015</year><volume>22</volume><fpage>10</fpage><pub-id pub-id-type="doi">10.1051/parasite/2015010</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taher</surname><given-names>M</given-names></name><name><surname>Tg Zakaria</surname><given-names>T</given-names></name><name><surname>Susanti</surname><given-names>D</given-names></name><name><surname>Zakaria</surname><given-names>ZA</given-names></name></person-group><article-title>Hypoglycaemic activity of ethanolic extract of <italic>Garcinia mangostana</italic> Linn. in normoglycaemic and streptozotocin-induced diabetic rats</article-title><source>BMC Complement. Altern. Med.</source><year>2016</year><volume>16</volume><fpage>135</fpage><pub-id pub-id-type="doi">10.1186/s12906-016-1118-9</pub-id><?supplied-pmid 27208974?><pub-id pub-id-type="pmid">27208974</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>MY</given-names></name><name><surname>Hashim</surname><given-names>NM</given-names></name><name><surname>Mariod</surname><given-names>AAA</given-names></name></person-group><article-title>&#x003b1;-mangostin from <italic>Garcinia mangostana</italic> Linn: An updated review of its pharmacological properties</article-title><source>Arab. J. Chem.</source><year>2016</year><volume>9</volume><fpage>317</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1016/j.arabjc.2014.02.011</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sunarjo</surname><given-names>L</given-names></name><name><surname>Suharti</surname><given-names>O</given-names></name><name><surname>Susanto</surname><given-names>HS</given-names></name></person-group><article-title>The preliminary study on safety of using mangosteen peel extract as natural herbs</article-title><source>JMSCR</source><year>2017</year><volume>50</volume><fpage>24851</fpage><lpage>24856</lpage></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakagami</surname><given-names>Y</given-names></name><name><surname>Iinuma</surname><given-names>M</given-names></name><name><surname>Piyasena</surname><given-names>KG</given-names></name><name><surname>Dharmaratne</surname><given-names>HR</given-names></name></person-group><article-title>Antibacterial activity of alpha-mangostin against vancomycin resistant Enterococci (VRE) and synergism with antibiotics</article-title><source>Phytomedicine</source><year>2005</year><volume>12</volume><fpage>203</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2003.09.012</pub-id><pub-id pub-id-type="pmid">15830842</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puripattanavong</surname><given-names>JKW</given-names></name><name><surname>Khajorndetkun</surname><given-names>W</given-names></name><name><surname>Chansathirapanich</surname><given-names>W</given-names></name></person-group><article-title>Improved isolation of &#x003b1;-mangostin from the fruit hull of <italic>Garcinia mangostana</italic>and its antioxidant and antifungal activity</article-title><source>Planta Med.</source><year>2006</year><volume>72</volume><fpage>1078</fpage><pub-id pub-id-type="doi">10.1055/S-2006-950128</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Husen</surname><given-names>SA</given-names></name><name><surname>Khaleyla</surname><given-names>F</given-names></name><name><surname>Ansori</surname><given-names>ANM</given-names></name><name><surname>Susilo</surname><given-names>RJK</given-names></name><name><surname>Winarni</surname><given-names>D</given-names></name></person-group><article-title>Antioxidant activity assay of alpha-mangostin for amelioration of kidney structure and function in diabetic mice</article-title><source>ASSEHR</source><year>2018</year><volume>98</volume><fpage>84</fpage><lpage>88</lpage></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aisha</surname><given-names>AF</given-names></name><name><surname>Abu-Salah</surname><given-names>KM</given-names></name><name><surname>Ismail</surname><given-names>Z</given-names></name><name><surname>Majid</surname><given-names>AM</given-names></name></person-group><article-title><italic>In vitro</italic> and <italic>in vivo</italic> anti-colon cancer effects of <italic>Garcinia mangostana</italic> xanthones extract</article-title><source>BMC Complement. Altern. Med.</source><year>2012</year><volume>12</volume><fpage>104</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1186/1472-6882-12-104</pub-id><pub-id pub-id-type="pmid">22818000</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JJ</given-names></name><name><surname>Sanderson</surname><given-names>BJ</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name></person-group><article-title>Cytotoxic effect of xanthones from pericarp of the tropical fruit mangosteen (<italic>Garcinia mangostana</italic> Linn.) on human melanoma cells</article-title><source>Food Chem. Toxicol.</source><year>2011</year><volume>49</volume><fpage>2385</fpage><lpage>2391</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2011.06.051</pub-id><pub-id pub-id-type="pmid">21723363</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>K</given-names></name><etal/></person-group><article-title>Induction of apoptosis by xanthones from mangosteen in human leukemia cell lines</article-title><source>J. Nat. Prod.</source><year>2003</year><volume>66</volume><fpage>1124</fpage><lpage>1127</lpage><pub-id pub-id-type="doi">10.1021/np020546u</pub-id><pub-id pub-id-type="pmid">12932141</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>LG</given-names></name><name><surname>Yang</surname><given-names>LL</given-names></name><name><surname>Wang</surname><given-names>CC</given-names></name></person-group><article-title>Anti-inflammatory activity of mangostins from <italic>Garcinia mangostana</italic></article-title><source>Food Chem. Toxicol.</source><year>2008</year><volume>46</volume><fpage>688</fpage><lpage>693</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2007.09.096</pub-id><pub-id pub-id-type="pmid">18029076</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Cen</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>Q</given-names></name></person-group><article-title>Immune regulation and anti-inflammatory effects of isogarcinol extracted from <italic>Garcinia mangostana</italic> L. against collagen-induced arthritis</article-title><source>J. Agric. Food Chem.</source><year>2014</year><volume>62</volume><fpage>4127</fpage><lpage>4134</lpage><pub-id pub-id-type="doi">10.1021/jf405790q</pub-id><pub-id pub-id-type="pmid">24738849</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riscoe</surname><given-names>M</given-names></name><name><surname>Kelly</surname><given-names>JX</given-names></name><name><surname>Winter</surname><given-names>R</given-names></name></person-group><article-title>Xanthones as antimalarial agents: Discovery, mode of action, and optimization</article-title><source>Curr. Med. Chem.</source><year>2005</year><volume>12</volume><fpage>2539</fpage><lpage>2549</lpage><pub-id pub-id-type="doi">10.2174/092986705774370709</pub-id><pub-id pub-id-type="pmid">16250876</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azebaze</surname><given-names>AG</given-names></name><name><surname>Meyer</surname><given-names>M</given-names></name><name><surname>Valentin</surname><given-names>A</given-names></name><name><surname>Nguemfo</surname><given-names>EL</given-names></name><name><surname>Fomum</surname><given-names>ZT</given-names></name><name><surname>Nkengfack</surname><given-names>AE</given-names></name></person-group><article-title>Prenylated xanthone derivatives with antiplasmodial activity from <italic>Allanblackia monticola</italic> STANER L.C</article-title><source>Chem. Pharm. Bull.</source><year>2006</year><volume>54</volume><fpage>111</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1248/cpb.54.111</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahabusarakam</surname><given-names>W</given-names></name><name><surname>Kuaha</surname><given-names>K</given-names></name><name><surname>Wilairat</surname><given-names>P</given-names></name><name><surname>Taylor</surname><given-names>WC</given-names></name></person-group><article-title>Prenylated xanthones as potential antiplasmodial substances</article-title><source>Planta Med.</source><year>2006</year><volume>72</volume><fpage>912</fpage><lpage>916</lpage><pub-id pub-id-type="doi">10.1055/s-2006-947190</pub-id><pub-id pub-id-type="pmid">16902859</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ansori</surname><given-names>ANM</given-names></name><etal/></person-group><article-title>A review on medicinal properties of mangosteen (<italic>Garcinia mangostana</italic> L.)</article-title><source>Res. J. Pharm. Technol.</source><year>2020</year><volume>13</volume><fpage>974</fpage><lpage>982</lpage><pub-id pub-id-type="doi">10.5958/0974-360X.2020.00182.1</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutierrez-Orozco</surname><given-names>F</given-names></name><name><surname>Failla</surname><given-names>ML</given-names></name></person-group><article-title>Biological activities and bioavailability of mangosteen xanthones: A critical review of the current evidence</article-title><source>Nutrients</source><year>2013</year><volume>5</volume><fpage>3163</fpage><lpage>3183</lpage><pub-id pub-id-type="doi">10.3390/nu5083163</pub-id><pub-id pub-id-type="pmid">23945675</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Upegui</surname><given-names>Y</given-names></name><etal/></person-group><article-title><italic>In vivo</italic> antimalarial activity of &#x003b1;-mangostin and the new xanthone &#x003b4;-mangostin</article-title><source>Phytother Res.</source><year>2015</year><volume>29</volume><fpage>1195</fpage><lpage>1201</lpage><pub-id pub-id-type="doi">10.1002/ptr.5362</pub-id><pub-id pub-id-type="pmid">25943035</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marciano-Cabral</surname><given-names>F</given-names></name><name><surname>Cabral</surname><given-names>G</given-names></name></person-group><article-title><italic>Acanthamoeba</italic> spp. as agents of disease in humans</article-title><source>Clin. Microbiol. Rev.</source><year>2003</year><volume>16</volume><fpage>273</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1128/CMR.16.2.273-307.2003</pub-id><pub-id pub-id-type="pmid">12692099</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pussard</surname><given-names>M</given-names></name><name><surname>Pons</surname><given-names>R</given-names></name></person-group><article-title>Morphologie de la paroi kystique et taxonomie du genre <italic>Acanthamoeba</italic> (Protozoa, Amoebida)</article-title><source>Protistologica</source><year>1977</year><volume>13</volume><fpage>557</fpage><lpage>598</lpage></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xuan</surname><given-names>YH</given-names></name><name><surname>Chung</surname><given-names>BS</given-names></name><name><surname>Hong</surname><given-names>YC</given-names></name><name><surname>Kong</surname><given-names>HH</given-names></name><name><surname>Hahn</surname><given-names>TW</given-names></name><name><surname>Chung</surname><given-names>DI</given-names></name></person-group><article-title>Keratitis by <italic>Acanthamoeba triangularis</italic>: Report of cases and characterization of isolates</article-title><source>Korean J. Parasitol.</source><year>2008</year><volume>46</volume><fpage>157</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.3347/kjp.2008.46.3.157</pub-id><pub-id pub-id-type="pmid">18830055</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bunsuwansakul</surname><given-names>C</given-names></name><etal/></person-group><article-title><italic>Acanthamoeba</italic> in Southeast Asia: Overview and Challenges</article-title><source>Korean J. Parasitol.</source><year>2019</year><volume>57</volume><fpage>341</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.3347/kjp.2019.57.4.341</pub-id><pub-id pub-id-type="pmid">31533401</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siddiqui</surname><given-names>R</given-names></name><name><surname>Aqeel</surname><given-names>Y</given-names></name><name><surname>Khan</surname><given-names>NA</given-names></name></person-group><article-title>The development of drugs against <italic>Acanthamoeba</italic> infections</article-title><source>Antimicrob. Agents Chemother.</source><year>2016</year><volume>60</volume><fpage>6441</fpage><lpage>6450</lpage><pub-id pub-id-type="doi">10.1128/AAC.00686-16</pub-id><pub-id pub-id-type="pmid">27600042</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fakae</surname><given-names>LB</given-names></name><name><surname>Stevenson</surname><given-names>CW</given-names></name><name><surname>Zhu</surname><given-names>XQ</given-names></name><name><surname>Elsheikha</surname><given-names>HM</given-names></name></person-group><article-title><italic>In vitro</italic> activity of <italic>Camellia sinensis</italic> (green tea) against trophozoites and cysts of <italic>Acanthamoeba castellanii</italic></article-title><source>Int. J. Parasitol. Drugs Drug Resist.</source><year>2020</year><volume>13</volume><fpage>59</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.ijpddr.2020.05.001</pub-id><pub-id pub-id-type="pmid">32512260</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anwar</surname><given-names>A</given-names></name><etal/></person-group><article-title>Antiamoebic activity of synthetic tetrazoles against <italic>Acanthamoeba castellanii</italic> belonging to T4 genotype and effects of conjugation with silver nanoparticles</article-title><source>Parasitol. Res.</source><year>2020</year><volume>119</volume><fpage>1943</fpage><lpage>1954</lpage><pub-id pub-id-type="doi">10.1007/s00436-020-06694-4</pub-id><pub-id pub-id-type="pmid">32385711</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheesman</surname><given-names>MJ</given-names></name><name><surname>Ilanko</surname><given-names>A</given-names></name><name><surname>Blonk</surname><given-names>B</given-names></name><name><surname>Cock</surname><given-names>IE</given-names></name></person-group><article-title>Developing new antimicrobial therapies: Are synergistic combinations of plant extracts/compounds with conventional antibiotics the solution?</article-title><source>Pharmacogn. Rev.</source><year>2017</year><volume>11</volume><fpage>57</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.4103/phrev.phrev_21_17</pub-id><pub-id pub-id-type="pmid">28989242</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elsheikha</surname><given-names>HM</given-names></name><name><surname>Siddiqui</surname><given-names>R</given-names></name><name><surname>Khan</surname><given-names>NA</given-names></name></person-group><article-title>Drug discovery against <italic>Acanthamoeba</italic> infections: Present knowledge and unmet needs</article-title><source>Pathogens</source><year>2020</year><volume>9</volume><fpage>405</fpage><pub-id pub-id-type="doi">10.3390/pathogens9050405</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fatimah</surname><given-names>H</given-names></name><name><surname>Nakisah</surname><given-names>MA</given-names></name></person-group><article-title>Visualization on the effect of chlorhexidine gluconate, a biocide on <italic>Acanthamoeba</italic> sp. by electron microscopy</article-title><source>Malays. J. Microsc.</source><year>2013</year><volume>9</volume><fpage>154</fpage><lpage>159</lpage></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hafeez</surname><given-names>BB</given-names></name><etal/></person-group><article-title>&#x003b1;-Mangostin: a dietary antioxidant derived from the pericarp of <italic>Garcinia mangostana</italic> L. inhibits pancreatic tumor growth in xenograft mouse model</article-title><source>Antioxid. Redox Signal.</source><year>2014</year><volume>21</volume><fpage>682</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.1089/ars.2013.5212</pub-id><pub-id pub-id-type="pmid">24295217</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaomongkolgit</surname><given-names>R</given-names></name><name><surname>Jamdee</surname><given-names>K</given-names></name><name><surname>Pumklin</surname><given-names>J</given-names></name><name><surname>Pavasant</surname><given-names>P</given-names></name></person-group><article-title>Laboratory evaluation of the antibacterial and cytotoxic effect of alpha-mangostin when used as a root canal irrigant</article-title><source>Indian J Dent.</source><year>2013</year><volume>4</volume><fpage>12</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.ijd.2012.12.006</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitsuwan</surname><given-names>W</given-names></name><etal/></person-group><article-title><italic>Curcuma longa</italic> ethanol extract and <italic>Curcumin</italic> inhibit the growth of <italic>Acanthamoeba triangularis</italic> trophozoites and cysts isolated from water reservoirs at Walailak University,Thailand</article-title><source>Pathog Glob. Health.</source><year>2020</year><volume>114</volume><fpage>194</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1080/20477724.2020.1755551</pub-id><pub-id pub-id-type="pmid">32315247</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lorian</surname><given-names>V</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Lorian</surname><given-names>V</given-names></name></person-group><article-title>Antibiotics</article-title><source>Laboratory Medicine</source><year>1996</year><publisher-loc>Baltimore</publisher-loc><publisher-name>Springer</publisher-name><fpage>69</fpage><lpage>71</lpage></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaomongkolgit</surname><given-names>R</given-names></name><name><surname>Jamdee</surname><given-names>K</given-names></name><name><surname>Chaisomboon</surname><given-names>N</given-names></name></person-group><article-title>Antifungal activity of alpha-mangostin against <italic>Candida albicans</italic></article-title><source>J. Oral Sci.</source><year>2009</year><volume>51</volume><fpage>401</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.2334/josnusd.51.401</pub-id><pub-id pub-id-type="pmid">19776506</pub-id></element-citation></ref></ref-list></back></article>